(Q35540194)

8 August 2017

1 reference

title

Corticobasal degeneration: selected developments (English)

1 reference

8 August 2017

Corticobasal degeneration: Selected developments (English)

1 reference

corticobasal degeneration

12 March 2024

main subject

1 reference

1 reference

12 March 2024

1

Anthony E Lang

1 reference

8 August 2017

Anthony E. Lang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502656

reference URL

12 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.10563

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/mds.10563

12 March 2024

1 reference

12 March 2024

1 reference

8 August 2017

18 Suppl 6

1 reference

8 August 2017

S51-6

1 reference

Neural and cognitive bases of upper limb apraxia in corticobasal degeneration

8 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10563

Crossref

reference URL

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10563

Crossref

reference URL

Corticodentatonigral Degeneration With Neuronal Achromasia

21 January 2018

1

1 reference

Cortical-basal ganglionic degeneration

12 March 2024

2

1 reference

Corticobasal degeneration

12 March 2024

3

1 reference

Pick's disease. Histological and clinical correlations.

12 March 2024

5

1 reference

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

12 March 2024

8

1 reference

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

12 March 2024

9

1 reference

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration.

12 March 2024

10

1 reference

Corticobasal syndrome with tau pathology

12 March 2024

12

1 reference

Dementia as the most common presentation of cortical-basal ganglionic degeneration.

12 March 2024

13

1 reference

Cortical basal ganglionic degeneration presenting with "progressive loss of speech output and orofacial dyspraxia"

12 March 2024

14

1 reference

Dystonia in corticobasal degeneration

12 March 2024

15

1 reference

The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease

12 March 2024

17

1 reference

Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy

12 March 2024

18

1 reference

The nature of apraxia in corticobasal degeneration

12 March 2024

19

1 reference

Neuropsychiatric features of corticobasal degeneration.

12 March 2024

20

1 reference

Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease.

12 March 2024

21

1 reference

Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography

12 March 2024

22

1 reference

Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.

12 March 2024

23

1 reference

Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques.

12 March 2024

24

1 reference

Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.

12 March 2024

26

1 reference

Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration

12 March 2024

28

1 reference

Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia.

12 March 2024

29

1 reference

Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease

12 March 2024

31

1 reference

Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.

12 March 2024

32

1 reference

Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration

12 March 2024

34

1 reference

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects

12 March 2024

35

1 reference

Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy

12 March 2024

36

1 reference

Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration

12 March 2024

37

1 reference

Treatment of dystonic clenched fist with botulinum toxin

12 March 2024

38

1 reference

Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy.

12 March 2024

39

1 reference

New insights into progressive supranuclear palsy

12 March 2024

40

1 reference

Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy

12 March 2024

41

1 reference

Further evidence for mitochondrial dysfunction in progressive supranuclear palsy

12 March 2024

42

1 reference

Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids.

12 March 2024

43

1 reference

Brain aconitase activity is not decreased in progressive supranuclear palsy.

12 March 2024

44

1 reference

Expression and activity of antioxidants in the brain in progressive supranuclear palsy

12 March 2024

45

1 reference

The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau.

12 March 2024

46

1 reference

Evidence for oxidative stress in Pick disease and corticobasal degeneration

12 March 2024

47

1 reference

12 March 2024

Identifiers

DOI

10.1002/MDS.10563

1 reference

8 August 2017

1 reference